Harmony Biosciences Holdings, Inc. (HRMY)
37.86
-0.09
(-0.24%)
USD |
NASDAQ |
Oct 19, 14:02
Harmony Biosciences Holdings Cash from Operations (Annual) : 348.20M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 348.20M |
| December 31, 2024 | 219.82M |
| December 31, 2023 | 219.39M |
| December 31, 2022 | 144.47M |
| Date | Value |
|---|---|
| December 31, 2021 | 98.56M |
| December 31, 2020 | -2.985M |
| December 31, 2019 | -75.44M |
| December 31, 2018 | -38.80M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Liquidia Corp. | -35.69M |
| Pfizer Inc. | 11.70B |
| Bristol Myers Squibb Co. | 14.16B |
| Repligen Corp. | 117.42M |
| Johnson & Johnson | 24.53B |